Replies to post #63082 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

DoGood DoWell,

I am guessing that NWBO might be addressing a need for; proof of production capacity ramp needed for European approval, manufacturing changes(upgrades) as per Rkmatters post(possible early trial vs later trial equivalency), possible ethicist intervention for mesenchymal/pseudos or at least rebalancing of patient subtypes if mesenchymal/ methlated mesenchymal population is under represented in the main cohort due to pseudo removal, an attempt to qualify and quantify potential patient benefit with UCLA biomarker test, probable gag order by legal counsel, and a potential FBI request to forego release of investigation results as long as possible so they can build their case(s) in a joint effort. Kind of like the FBI's Wall Street target version of the Manhatten Project.